Skip to content
value.today

Health Precision Inc.

Total raised
$30 M
3 rounds on record
Latest round
$20 M
Jun 2025
First round on record
Jun 2023
Today
Private
No later event on record

Funding rounds

3 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Health Precision Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Jun 2025$20 MNo. 3$10 to $50 million

Health Precision Inc.: Raise no. 3, Jun 2025

Investors in this round

2 investors had bought by the notice of Sep 2, 2025: 2 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$20 M of $20 M offered
Smallest investment taken
no minimum stated
What was sold
options or other rights to buy securities, other: Convertible debt
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Avin Joshi · Executive Officer
  • Eyal Ephrat, MD · Executive Officer, Director
  • Sonia Ben-Yehuda · Executive Officer, Director
  • Edgar Jannotta · Director
  • Rahul M. Rajkumar · Director
  • Richard M. Burridge Jr. · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Eyal Ephrat, MD, Ceo. Source: SEC Form D, newest notice filed Sep 2, 2025. Read the notice at the SEC.

optionsSEC
Jul 2024$4 MNo. 2$2 to $10 million

Health Precision Inc.: Raise no. 2, Jul 2024

Investors in this round

22 investors had bought by the notice of Feb 5, 2025: 22 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$4 M of $10 M offered; $6 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity, options or other rights to buy securities
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
$93,500
Finders' fees
none
Paid to its own people
$100,000 (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks payments to its own people as estimates
The company
Corporation, incorporated in Delaware

People named in the notice

  • Avin B. Joshi · Executive Officer
  • Eyal Ephrat · Executive Officer, Director
  • Sonia Ben-Yehuda · Executive Officer, Director
  • Edgar D. Jannotta, Jr. · Director
  • Ninfa B. Saunders · Director
  • Olin W Nisbet · Director
  • Paul B. Guenther · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

  • Arcadia Securities, LLC (CRD 44656) · broker-dealer Arcadia Securities, LLC (CRD 44656) · New York, New YorkSold in FL, IL, NY, SC, TX, VA

Remarks in the notice

  • On the use of proceeds: “Portion of salaries to be paid in ordinary course of business.”

Signed by Avin Joshi, Chief Operating Officer. Source: SEC Form D, newest notice filed Feb 5, 2025. Read the notice at the SEC.

equity, optionsSEC
Jun 2023$5 MNo. 1$2 to $10 million

Health Precision Inc.: Raise no. 1, Jun 2023

Investors in this round

22 investors had bought by the notice of Aug 8, 2023: 22 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$5 M of $8 M offered; $3 M still to sell
Smallest investment taken
no minimum stated
What was sold
debt, options or other rights to buy securities
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
$245,000 (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks payments to its own people as estimates
The company
Corporation, incorporated in Delaware

People named in the notice

  • Avin B. Joshi · Executive Officer
  • Eyal Ephrat · Executive Officer, Director
  • Sonia Ben-Yehuda · Executive Officer, Director
  • Edgar D. Jannotta, Jr. · Director
  • Ninfa B. Saunders · Director
  • Paul B. Guenther · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the use of proceeds: “Portion of salaries to be paid in ordinary course of business.”

Signed by Eyal Ephrat, M.D., Chief Executive Officer. Source: SEC Form D and 1 amendment, newest notice filed Aug 8, 2023. Read the notice at the SEC.

debt, optionsSEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Health Precision Inc. chose not to state its revenue in its newest notice of a funding round (Sep 2025).

    SEC Form D · Sep 2025

  • The industry group it chose in its notices: Other Technology.

    SEC Form D · Sep 2025

That is all the official record says: Health Precision Inc. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of Health Precision Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 3 rounds above had up to 22 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Health Precision Inc.
NameRoleNamed in
Avin JoshiExecutive officerSep 2025
Eyal Ephrat, MDExecutive officerSep 2025
Sonia Ben-YehudaExecutive officerSep 2025
Avin B. JoshiExecutive officerFeb 2025
Eyal EphratExecutive officerFeb 2025
Edgar JannottaDirectorSep 2025
Eyal Ephrat, MDDirectorSep 2025
Rahul M. RajkumarDirectorSep 2025
Richard M. Burridge Jr.DirectorSep 2025
Sonia Ben-YehudaDirectorSep 2025
Edgar D. Jannotta, Jr.DirectorFeb 2025
Eyal EphratDirectorFeb 2025
Ninfa B. SaundersDirectorFeb 2025
Olin W NisbetDirectorFeb 2025
Paul B. GuentherDirectorFeb 2025